Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

National Institute of Environmental Health Sciences

Use this QR code to view the newest version of this document

Your Environment. Your Health.

Project Publications: University of Arizona: The Human Genetics of Arsenic Biotransformation

Superfund Research Program

The Human Genetics of Arsenic Biotransformation

Project Leader: H. Vasken Aposhian
Grant Number: P42ES004940
Funding Period: 2000-2010
View this project in the NIH Research Portfolio Online Reporting Tools (RePORT)

Project-Specific Links

Connect with the Grant Recipients

Visit the grantee's eNewsletter page Visit the grantee's eNewsletter page Visit the grantee's Twitter page Visit the grantee's Instagram page Visit the grantee's Video page

Publications

2008

  • Chowdhury UK, Aposhian HV. 2008. Protein expression in the livers and urinary bladders of hamsters exposed to sodium arsenite. Ann N Y Acad Sci 1140:325-334. doi:10.1196/annals.1454.019 PMID:18991932

2006

  • Aposhian HV, Aposhian MM. 2006. Arsenic toxicology: five questions (review). Chem Res Toxicol 19(1):1-15. PMID:16411650
  • Chowdhury UK, Zakharyan RA, Hernandez A, Avram MD, Kopplin MJ, Aposhian HV. 2006. Glutathione-S-transferase-omega [MMA(V) reductase] knockout mice: enzyme and arsenic species concentrations in tissues after arsenate administration. Toxicol Appl Pharmacol 216(3):446-457. doi:10.1016/j.taap.2006.06.014 PMID:16930657

2005

  • Kirkpatrick DS, Weldon SF, Tsaprailis G, Liebler DC, Gandolfi A. 2005. Proteomic identification of ubiquitinated proteins from human cells expressing His-tagged ubiquitin. Proteomics 5(8):2104-2111. PMID:15852347
  • Meza MM, Yu L, Rodriguez YY, Guild M, Thompson D, Gandolfi A, Klimecki WT. 2005. Developmentally restricted genetic determinants of human arsenic metabolism: association between urinary methylated arsenic and CYT19 polymorphisms in children. Environ Health Perspect 113(6):775-781. PMID:15929903
  • Zakharyan RA, Tsaprailis G, Chowdhury UK, Hernandez A, Aposhian HV. 2005. Interactions of sodium selenite, glutathione, arsenic species, and omega class human glutathione transferase. Chem Res Toxicol 18(8):1287-1295. doi:10.1021/tx0500530 PMID:16097802

2004

  • Bredfeldt TG, Kopplin MJ, Gandolfi A. 2004. Effects of arsenite on UROtsa cells: low-level arsenite causes accumulation of ubiquitinated proteins that is enhanced by reduction in cellular glutathione levels. Toxicol Appl Pharmacol 198(3):412-418. PMID:15276421

2003

  • Aposhian HV, Zakharyan RA, Avram MD, Kopplin MJ, Wollenberg ML. 2003. Oxidation and detoxification of trivalent arsenic species. Toxicol Appl Pharmacol 193(1):1-8. PMID:14613711
  • Aposhian HV, Zakharyan RA, Healy SM, Wildfang E, Petrick JS, Sampayo-Reyes A, Board PG, Carter DE, Mazumder G, Aposhian MM. 2003. Enzymology and Toxicity of Inorganic Arsenic. In: Arsenic Exposure and Health Effects: Proceedings of the Fifth International Conference on Arsenic Exposure and Health Effects, San Diego, California. Elsiever Science Ltd., Oxford, United Kingdom. pp.225-240.
  • Carter DE, Aposhian HV, Gandolfi A. 2003. The metabolism of inorganic arsenic oxides, gallium arsenide, and arsine: a toxicochemical review. Toxicol Appl Pharmacol 193(3):309-334. PMID:14678742
  • Chowdhury UK, Rahman MM, Sengupta MK, Lodh D, Chanda CR, Roy S, Quamruzzaman Q, Tokunaga H, Ando M, Chakraborti DK. 2003. Pattern of excretion of arsenic compounds [arsenite, arsenate, MMA(V), DMA(V)] in urine of children compared to adults from an arsenic exposed area in Bangladesh. J Environ Sci Health A Tox Hazard Subst Environ Eng 38(1):87-113. PMID:12635821
  • Yu L, Kalla K, Guthrie E, Vidrine A, Klimecki WT. 2003. Genetic variation in genes associated with arsenic metabolism: GST-Omega and Purine Nucleoside Phosphorylase polymorphisms in European and Indigenous Americans. EHP Toxicogenomics 111(11):1421-1428.

2002

  • Gong Z, Jiang G, Cullen WR, Aposhian HV. 2002. Determination of arsenic metabolic complex excreted in human urine after administration of sodium 2,3-dimercapto-1-propane sulfonate. Chem Res Toxicol 15(10):1318-1323. PMID:12387631
  • Mukhopadhyay R, Rosen BP. 2002. Arsenate reductases in prokaryotes and eukaryotes. Environ Health Perspect 110(5):745-748. PMID:12426124
  • Radabaugh TR, Sampayo-Reyes A, Zakharyan RA, Aposhian HV. 2002. Arsenate reductase II. Purine nucleoside phophorylase in the presence of dihydrolipoic acid is a route for reduction of arsenate to arsenite in mammalian systems. Chem Res Toxicol 15(5):692-698.
  • Rosen BP. 2002. Biochemistry of arsenic detoxification. FEBS Lett 529(1):86-97. PMID:12354618

2001

  • Aposhian HV, Aposhian MM. 2001. Arsenic mobilization by DMPS. In: Arsenic Exposure and Health Effects IV. Elsevier, New York, NY. pp.397-406.
  • Aposhian HV, Gurzau ES, Le X, Gurzau A, Zakharyan RA, Cullen WR, Healy SM, Gonzalez-Ramirez D, Morgan DL, Sampayo-Reyes A, Wildfang E, Radabaugh TR, Petrick JS, Mash EA, Aavula RB, Aposhian MM. 2001. The discovery, importance and siginificance of monomethyl-arsonous acid (MMAIII) in urine of humans exposed to inorganic arsenic. In: Arsenic Exposure and Health Effects IV. Elsevier, New York, NY. pp.305-314.
  • Petrick JS, Jagadish B, Mash EA, Aposhian HV. 2001. Monomethylarsonous acid (MMAIII) and arsenite: LD50 in hamsters and in vitro inhibition of pyruvate dehydrogenase. Chem Res Toxicol 14(6):651-656. PMID:11409934
  • Wildfang E, Radabaugh TR, Aposhian HV. 2001. Enzymatic methylation of arsenic compounds. IX. Liver arsenite methyltransferase and arsenate reductase activities in primates. Toxicology 168(3):213-221. PMID:11684318
  • Zakharyan RA, Sampayo-Reyes A, Healy SM, Tsaprailis G, Board PG, Liebler DC, Aposhian HV. 2001. Human monomethylarsonic acid (MMAV) reductase is a member of the glutathione-S-transferase superfamily. Chem Res Toxicol 14(8):1051-1057. PMID:11511179

2000

  • Aposhian HV, Aposhian MM. 2000. Arsenic mobilization by DMPS. In: Proceedings of the Fourth International Conference on Arsenic Exposure and Health Effects. San Diego, CA.
  • Aposhian HV, Gurzau ES, Le X, Gurzau A, Healy SM, Lu X, Ma M, Yip L, Zakharyan RA, Maiorino RM, Dart RC, Tircus MG, Gonzalez-Ramirez D, Morgan DL, Avram D, Aposhian MM. 2000. Occurrence of monomethylarsonous acid (MMAIII) in urine of humans exposed to inorganic arsenic. Chem Res Toxicol 13(8):693-697. PMID:10956055
  • Aposhian HV, Gurzau ES, Le X, Gurzau A, Zakharyan RA, Cullen WR, Healy SM, Gonzalez-Ramirez D, Morgan DL, Sampayo-Reyes A, Wildfang E, Radabaugh TR, Petrick JS, Mash EA, Aavula RB, Aposhian MM. 2000. The discovery, importance and significance of monomethyl- arsonous acid (MMAIII) in urine of humans exposed to inorganic arsenic. In: Proceedings of the Fourth International Conference on Arsenic Exposure and Health Effects. San Diego, CA.
  • Gailer J, George GN, Pickering IJ, Prince RC, Ringwald SC, Pemberton JE, Glass RS, Younis HS, DeYoung DW, Aposhian HV. 2000. A metabolic link between arsenite and selenite: The seleno-bis(S-glutathionyl) arsinium ion. J Am Chem Soc 122(19):4637-4639.
  • Le X, Lu X, Ma M, Cullen WR, Aposhian HV, Zheng B. 2000. Speciation of key arsenic metabolic intermediates in human urine. Anal Chem 72(21):5172-5177. PMID:11080860
  • Le X, Ma M, Lu X, Cullen WR, Aposhian HV, Zheng B. 2000. Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine. Environ Health Perspect 108(11):1015-1018. PMID:11102289
  • Petrick JS, Ayala-Fierro F, Cullen WR, Carter DE, Aposhian HV. 2000. The most toxic arsenical in the inorganic arsenic biotransformation pathway. In: Proceedings of the Fourth International Conference on Arsenic Exposure and Health Effects. San Diego, CA.
  • Radabaugh TR, Aposhian HV. 2000. Enzymatic reduction of arsenic compounds in mammalian systems: reduction of arsenate to arsenite by human liver arsenate reductase. Chem Res Toxicol 13(1):26-30. PMID:10649963
  • Sampayo-Reyes A, Zakharyan RA, Aposhian HV. 2000. Monomethylarsonic acid MMA (V) reductase activity in hamster tissues. In: Proceedings of the Fourth International Conference on Arsenic Exposure and Health Effects. San Diego, CA.
  • Sampayo-Reyes A, Zakharyan RA, Healy SM, Aposhian HV. 2000. Monomethylarsonic acid (MMAV) reductase and monomethylarsonous acid (MMAIII) in hamster tissue. Chem Res Toxicol 13(11):1181-1186.
  • Wildfang E, Healy SM, Aposhian HV. 2000. Arsenic. In: Molecular Biology and Toxicology of Metals. Taylor and Francis Inc., London, United Kingdom. pp.75-112.

1999

  • Zakharyan RA, Aposhian HV. 1999. Enzymatic reduction of arsenic compounds in mammalian systems: the rate limiting enzyme of rabbit liver arsenic biotransformation is MMAV reductase. Chem Res Toxicol 12(12):1278-1283. PMID:10604879
  • Zakharyan RA, Ayala-Fierro F, Cullen WR, Carter DE, Aposhian HV. 1999. Enzymatic methylation of arsenic compounds: VII. Monomethylarsonous acid (MMAIII) is the substrate for MMA methyltransferase of rabbit liver and human hepatocytes. Toxicol Appl Pharmacol 158(1):9-15. PMID:10387927

1998

  • Echeverria D, Aposhian HV, Woods JS, Heyer NJ, Aposhian MM, Bittner AC, Mahurin RK, Cianciola ME. 1998. Neurobehavioral effects from exposure to dental amalgam Hgo: new distinctions between recent exposure and Hg body burden. FASEB J 12(11):971-980. PMID:9707169
Back
to Top